Arlington Financial Advisors, LLC Pfizer Inc Transaction History

Arlington Financial Advisors, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 17, 2024	SELL	$25.89 - $29.73 $40,129 - $46,081	-1,550 Reduced 11.31%	12,155 $337,000
Q4 2023 Jan 08, 2024	SELL	$26.13 - $33.94 $165,794 - $215,349	-6,345 Reduced 31.65%	13,705 $394,000
Q2 2023 Jul 24, 2023	SELL	$36.12 - $41.79 $3,900 - $4,513	-108 Reduced 0.54%	20,050 $735,000
Q1 2023 May 05, 2023	BUY	$39.39 - $51.28 $57,430 - $74,766	1,458 Added 7.8%	20,158 $822,000
Q4 2022 Jan 18, 2023	SELL	$41.75 - $54.5 $54,275 - $70,850	-1,300 Reduced 6.5%	18,700 $0
Q3 2022 Oct 18, 2022	SELL	$43.76 - $53.42 $3,282 - $4,006	-75 Reduced 0.37%	20,000 $875,000
Q2 2022 Jul 13, 2022	BUY	$46.53 - $55.17 $2,000 - $2,372	43 Added 0.21%	20,075 $1.05 Million
Q1 2022 Apr 26, 2022	BUY	$45.75 - $56.69 $823 - $1,020	18 Added 0.09%	20,032 $1.04 Million
Q2 2021 Jul 30, 2021	BUY	$35.91 - $40.68 $718,702 - $814,169	20,014 New	20,014 $784,000
Q1 2019 May 13, 2019	SELL	$37.5 - $41.2 $227,850 - $250,331	-6,076 Closed	0 $0
Q4 2018 Jan 17, 2019	BUY	$38.47 - $43.86 $233,743 - $266,493	6,076 New	6,076 $265,000

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $148B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Arlington Financial Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Arlington Financial Advisors, LLC with notifications on news.